Accumulating evidence suggests that microglial cells in the spinal cord play an important role in the development of neuropathic pain. However, it remains largely unknown how glia interact with neurons in the spinal cord after peripheral nerve injury. Recent studies suggest that the chemokine fractalkine may mediate neural/microglial interaction via its sole receptor CX3CR1. We have examined how fractalkine activates microglia in a neuropathic pain condition produced by spinal nerve ligation (SNL). SNL induced an upregulation of CX3CR1 in spinal microglia that began on day 1, peaked on day 3, and maintained on day 10. Intrathecal injection of a neutralizing antibody against CX3CR1 suppressed not only mechanical allodynia but also the activation of p38 MAPK in spinal microglia following SNL. Conversely, intrathecal infusion of fractalkine produced a marked p38 activation and mechanical allodynia. SNL also induced a dramatic reduction of the membrane-bound fractalkine in the dorsal root ganglion, suggesting a cleavage and release of this chemokine after nerve injury. Finally, application of fractalkine to spinal slices did not produce acute facilitation of excitatory synaptic transmission in lamina II dorsal horn neurons, arguing against a direct action of fractalkine on spinal neurons. Collectively, our data suggest that (a) fractalkine cleavage (release) after nerve injury may play an important role in neural-glial interaction, and (b) microglial CX3CR1/p38 MAPK pathway is critical for the development of neuropathic pain.
Introduction
Chronic pain resulting from nerve damage can be intractable. Analgesic drugs used for treating acute pain are not very eVective for neuropathic pain, in part due to our incomplete understanding of the mechanisms underlying the development and maintenance of neuropathic pain. Increasing evidence shows that spinal microglia are activated after nerve injury and contribute to the development of neuropathic pain. Nerve injury induces the expression of microglial markers (e.g., CD11b, TLR4, CD14) within several hours (DeLeo et al., 2004) . Microglia are regarded as a major source for the production of proinXammatory cytokines (Hanisch, 2002; Koistinaho and Koistinaho, 2002) that are implicated in pain facilitation (DeLeo and Yezierski, 2001; Watkins et al., 2001) . Nerve injury upregulates several receptors, such as the chemokine receptors CCR2 and CX3CR1 and the ATP receptor P2X4 in spinal microglia; blocking or deleting these receptors results in decreased neuropathic pain (Abbadie et al., 2003; Tsuda et al., 2003 Tsuda et al., , 2005 Milligan et al., 2004; Verge et al., 2004) . A microglial inhibitor minocycline has been shown to prevent/delay neuropathic pain (Raghavendra et al., 2003; Ledeboer et al., 2005) and to attenuate a central neuropathic pain after spinal cord injury (Hains and Waxman, 2006) .
